- Early-stage venture capital firm US Venture Partners (USVP) announced it closed USVP XII, which is a $340 million fund designed to invest in early-stage companies
Early-stage venture capital firm US Venture Partners (USVP) announced it closed USVP XII, which is a $340 million fund designed to invest in leading companies in cybersecurity, enterprise software, consumer, and healthcare.
USVP XII is considered the successor to USVP XI, which was a $300 million fund that is now fully deployed. So far, USVP has led investments in 88 companies that completed initial public offerings and 85 more that were profitably acquired.
“With USVP XII, we are pleased to continue building on our extensive track record of successful early-stage VC investing,” said Rick Lewis, General Partner at USVP. “In addition to a multi-decade track record of success, USVP has demonstrated exceptionally strong performance in recent years. In the last three years, USVP portfolio company exits have generated $933 million in proceeds to USVP funds. Over the past decade, USVP has distributed over $2 billion to our investors. And 2019 was the eighth consecutive year that USVP distributions to limited partners exceeded called capital.”
USVP’s strategy is to be the lead Series A investor in companies based in the US or Israel in four core sectors, including cybersecurity, enterprise software, consumer, and healthcare – including the emerging digital health sector.
“USVP is a proven leader in our areas of focus. USVP companies like Inspire Medical Systems, ThreatMetrix, Box, HotelTonight, Pluto TV and Omada Health are all leading companies in massive global markets,” added Steve Krausz, General Partner at U.S. Venture Partners. “Our team has achieved strong results by investing in proven entrepreneurs leading companies in the early stages of development, in sectors where the USVP team has deep domain expertise. We have been fortunate that many of those companies have gone on to become the undisputed leaders in their industries and markets. And we continue to innovate within our firm to assure we are at the leading edge to meet the rapid pace of change in technology.”
The USVP XII investment team includes an experienced group of six partners, including Krausz, Lewis, Jonathan Root, Casey Tansey, Dafina Toncheva and Jacques Benkoski.
“All of the USVP partners have operating experience and a strong venture investment track record in their investment sectors,” explained Tansey. “The USVP team, strategy, and results enable us to attract world-class entrepreneurs. Our experience allows the USVP team to be true company-building partners to our management teams, as they seek to transform and create leading global industries. We deeply respect the entrepreneurs with whom we work. We are also proud and honored to have earned the confidence of the sophisticated Limited Partners in the US and around the world who have invested in our new fund, USVP XII.”
